Clinical Trials · NCT05726227
A Research Study on How Well Semaglutide Helps Children and Teenagers With Excess Body Weight Lose Weight
- Phase
- Phase 3
- Recruitment status
- Active Not Recruiting
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 210
- Start date
- Jul 2023
- Locations
- 56 sites, 10 countries
- Primary endpoint
- Group Kids: Change in body mass index (BMI)